drugset / Trial / NCT02985229

Acceptability and Feasibility of Medical Abortion in Singapore

NCT02985229

Phase 3 Completed 130 enrolled Gynuity Health Projects
NaSingle-groupOpen-labelTreatment

Summary

To test the hypothesis that a regimen of 200 mg oral mifepristone, with the option of home administration, followed by 800 μg buccal misoprostol 24 hours later for abortion through 70 days LMP will be feasible and acceptable in Singapore.

Timeline

Start
2016-10
Primary completion
2017-07
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Mifepristone Small molecule 200 mg Oral
Subject Misoprostol Other / unclassified 800 ug Other

Indications

No indication recorded.